{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:51:02Z","timestamp":1783572662783,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>We describe the evolution of caval valve implantation (CAVI) as a treatment for severe symptomatic tricuspid regurgitation (TR) in the high surgical risk patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Surgical treatment of severe TR is often limited by the high surgical risk of the patients who tend to develop severe secondary TR. Coaptation, annuloplasty, and orthotopic replacement strategies are all limited by annular and leaflet geometry, prior valve repair, and the presence of cardiac implantable device leads. CAVI appears to be a treatment strategy for severe symptomatic TR that improves functional capacity and quality of life while also reducing edema and ascites and improving cardiac output. Chronic kidney disease is a common comorbidity of patients with severe TR; zero-contrast CAVI has been described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Severe TR is undertreated, yet common in the elderly structural heart disease population. The evolution of CAVI as a viable treatment for severe TR underscores the deleterious systemic contribution of backwards flow to morbidity and mortality. There are good safety and efficacy outcomes from registry data using the TricValve platform. Randomized controlled trials for CAVI versus medical therapy for severe TR are ongoing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-024-02190-8","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:03:42Z","timestamp":1736226222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcatheter Caval Implantation for Severe Tricuspid Regurgitation"],"prefix":"10.1007","volume":"27","author":[{"given":"Vincent","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdul-Jawad Altisent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2190_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jacc.2019.04.028","volume":"74","author":"AL Axtell","year":"2019","unstructured":"Axtell AL, Bhambhani V, Moonsamy P, Healy EW, Picard MH, Sundt TM, et al. Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74:715\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"2190_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pcad.2019.10.009","volume":"62","author":"M Enriquez-Sarano","year":"2019","unstructured":"Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, Tribouilloy C, Benfari G, Michelena H. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis. 2019;62:447\u201351.","journal-title":"Prog Cardiovasc Dis"},{"key":"2190_CR3","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.jacc.2017.10.039","volume":"70","author":"CJ Zack","year":"2017","unstructured":"Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70:2953\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"2190_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/CIRCINTERVENTIONS.109.878983","volume":"2","author":"S Agarwal","year":"2009","unstructured":"Agarwal S, Tuzcu EM, Rodriguez ER, Tan CD, Rodriguez LL, Kapadia SR. Interventional Cardiology Perspective of functional tricuspid regurgitation. Circ Cardiovasc Interv. 2009;2:565\u201373.","journal-title":"Circ Cardiovasc Interv"},{"key":"2190_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","volume":"43","author":"J Nath","year":"2004","unstructured":"Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2190_CR6","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMra2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"Hahn RT. Tricuspid regurgitation. N Engl J Med. 2023;388:1876\u201391.","journal-title":"N Engl J Med"},{"key":"2190_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jchf.2023.07.020","volume":"11","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Brener MI, Cox ZL, Pinney S, Lindenfeld J. Tricuspid Regurgitation Management for Heart failure. JACC Heart Fail. 2023;11:1084\u2013102.","journal-title":"JACC Heart Fail"},{"key":"2190_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMra2207410","volume":"388","author":"BA Houston","year":"2023","unstructured":"Houston BA, Brittain EL, Tedford RJ. Right ventricular failure. N Engl J Med. 2023;388:1111\u201325.","journal-title":"N Engl J Med"},{"key":"2190_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/ejcts\/ezz160","volume":"57","author":"J Chen","year":"2020","unstructured":"Chen J, Hu K, Ma W, Lv M, Shi Y, Liu J, et al. Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution. Eur J Cardiothorac Surg. 2020;57:142\u201350.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2190_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.athoracsur.2022.12.041","volume":"115","author":"Q Chen","year":"2023","unstructured":"Chen Q, Bowdish ME, Malas J, Roach A, Gill G, Rowe G, et al. Isolated Tricuspid operations: the Society of thoracic surgeons adult cardiac surgery database analysis. Ann Thorac Surg. 2023;115:1162\u201370.","journal-title":"Ann Thorac Surg"},{"key":"2190_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.athoracsur.2013.06.031","volume":"96","author":"A Kilic","year":"2013","unstructured":"Kilic A, Saha-Chaudhuri P, Rankin JS, Conte JV. Trends and outcomes of Tricuspid Valve Surgery in North America: an analysis of more Than 50,000 patients from the Society of thoracic surgeons database. Ann Thorac Surg. 2013;96:1546\u201352.","journal-title":"Ann Thorac Surg"},{"key":"2190_CR12","doi-asserted-by":"crossref","unstructured":"Chen V, Altisent OA-J, Puri R. A comprehensive overview of surgical and transcatheter therapies to treat tricuspid regurgitation in patients with heart failure. Curr Opin Cardiol. 2023.","DOI":"10.1097\/HCO.0000000000001110"},{"key":"2190_CR13","doi-asserted-by":"publisher","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2021;143:E72\u2013227. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000000923","DOI":"10.1161\/CIR.0000000000000923"},{"key":"2190_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.xjon.2020.05.009","volume":"3","author":"J Chikwe","year":"2020","unstructured":"Chikwe J, Megna D. Rationale and surgical strategy for concomitant tricuspid repair. JTCVS Open. 2020;3:52\u201361.","journal-title":"JTCVS Open"},{"key":"2190_CR15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jacc.2015.01.059","volume":"65","author":"J Chikwe","year":"2015","unstructured":"Chikwe J, Itagaki S, Anyanwu A, Adams DH. Impact of concomitant tricuspid annuloplasty on Tricuspid Regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol. 2015;65:1931\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"2190_CR16","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.jacc.2019.09.028","volume":"74","author":"M Taramasso","year":"2019","unstructured":"Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, et al. Transcatheter Versus Medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74:2998\u20133008.","journal-title":"J Am Coll Cardiol"},{"key":"2190_CR17","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1016\/j.jcin.2020.07.008","volume":"13","author":"RT Hahn","year":"2020","unstructured":"Hahn RT, Kodali S, Fam N, Bapat V, Bartus K, Rod\u00e9s-Cabau J, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv. 2020;13:2482\u201393.","journal-title":"JACC Cardiovasc Interv"},{"key":"2190_CR18","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","volume":"388","author":"P Sorajja","year":"2023","unstructured":"Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023;388:1833\u201342.","journal-title":"N Engl J Med"},{"key":"2190_CR19","volume-title":"TRISCEND II: a randomized trial of transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation","author":"S Kodali","year":"2023","unstructured":"Kodali S. TRISCEND II: a randomized trial of transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation. San Francisco, CA: TCT; 2023."},{"key":"2190_CR20","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.3390\/jcm10194601","volume":"10","author":"O Abdul-Jawad Altisent","year":"2021","unstructured":"Abdul-Jawad Altisent O, Benetis R, Rumbinaite E, Mizarien V, Codina P, Gual-Capllonch F, et al. Caval Valve Implantation (CAVI): an emerging therapy for treating severe tricuspid regurgitation. J Clin Med. 2021;10:4601.","journal-title":"J Clin Med"},{"key":"2190_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jacc.2009.09.034","volume":"55","author":"A Lauten","year":"2010","unstructured":"Lauten A, Figulla HR, Willich C, Jung C, Rademacher W, Schubert H, et al. Heterotopic Valve Replacement as an Interventional Approach to Tricuspid Regurgitation. J Am Coll Cardiol. 2010;55:499\u2013500.","journal-title":"J Am Coll Cardiol"},{"key":"2190_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/eurheartj\/ehr028","volume":"32","author":"A Lauten","year":"2011","unstructured":"Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 2011;32:1207\u201313.","journal-title":"Eur Heart J"},{"key":"2190_CR23","doi-asserted-by":"crossref","unstructured":"Lauten A, Figulla HR, Unbehaun A, Fam N, Schofer J, Doenst T et al. Interventional treatment of severe tricuspid regurgitation. Circ Cardiovasc Interv. 2018;11.","DOI":"10.1161\/CIRCINTERVENTIONS.117.006061"},{"key":"2190_CR24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4244\/EIJ-D-19-00901","volume":"15","author":"H Dreger","year":"2020","unstructured":"Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, et al. Treatment of severe TRIcuspid regurgitation in patients with Advanced Heart failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial. EuroIntervention. 2020;15:1506\u201313.","journal-title":"EuroIntervention"},{"key":"2190_CR25","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jcin.2022.05.022","volume":"15","author":"R Est\u00e9vez-Loureiro","year":"2022","unstructured":"Est\u00e9vez-Loureiro R, S\u00e1nchez-Recalde A, Amat-Santos IJ, Cruz-Gonz\u00e1lez I, Baz JA, Pascual I, et al. 6-Month outcomes of the TricValve System in patients with tricuspid regurgitation. JACC Cardiovasc Interv. 2022;15:1366\u201377.","journal-title":"JACC Cardiovasc Interv"},{"key":"2190_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jcin.2023.10.043","volume":"17","author":"S Blasco-Turri\u00f3n","year":"2024","unstructured":"Blasco-Turri\u00f3n S, Briedis K, Est\u00e9vez-Loureiro R, S\u00e1nchez-Recalde A, Cruz-Gonz\u00e1lez I, Pascual I, et al. Bicaval TricValve Implantation in patients with severe symptomatic tricuspid regurgitation. JACC Cardiovasc Interv. 2024;17:60\u201372.","journal-title":"JACC Cardiovasc Interv"},{"key":"2190_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s00392-022-02029-8","volume":"111","author":"O Abdul-Jawad Altisent","year":"2022","unstructured":"Abdul-Jawad Altisent O, Codina P, Puri R, Bay\u00e9s-Gen\u00eds A. Transcatheter bi-caval valve implantation (CAVI) significantly improves cardiac output: mechanistic insights following CardioMEMS\u00ae and TricValve\u00ae implantation. Clin Res Cardiol. 2022;111:966\u20138.","journal-title":"Clin Res Cardiol"},{"key":"2190_CR28","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.4244\/EIJ-D-23-00077","volume":"19","author":"IJ Amat-Santos","year":"2023","unstructured":"Amat-Santos IJ, Estevez-Loureiro R, S\u00e1nchez-Recalde \u00c1, Cruz-Gonz\u00e1lez I, Pascual I, Mascherbauer J, et al. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation. EuroIntervention. 2023;19:e450\u20132.","journal-title":"EuroIntervention"},{"key":"2190_CR29","doi-asserted-by":"publisher","unstructured":"Sherif M, Schmidt A, Path JR, Rheinthaler M, Trippel TD. UNICA - a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency. EuroIntervention [Internet]. 2024;20:107\u20138. Available from: https:\/\/eurointervention.pcronline.com\/doi\/https:\/\/doi.org\/10.4244\/EIJ-D-23-00503","DOI":"10.4244\/EIJ-D-23-00503"},{"key":"2190_CR30","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.jaccas.2023.102103","volume":"28","author":"A Sisinni","year":"2023","unstructured":"Sisinni A, Est\u00e9vez-Loureiro R, Caneiro-Queija B, Barreiro-P\u00e9rez M, Baz JA, Pazos P, et al. First-in-human treatment of severe tricuspid regurgitation using a Novel Cross-caval Heterotopic device. JACC Case Rep. 2023;28:102103.","journal-title":"JACC Case Rep"},{"key":"2190_CR31","doi-asserted-by":"publisher","first-page":"102007","DOI":"10.1016\/j.jaccas.2023.102007","volume":"23","author":"K Denby","year":"2023","unstructured":"Denby K, Spilias N, Harb SC, Kapadia SR, Puri R. Contrast-sparing intravascular ultrasound\u2013guided caval valve implantation for severe symptomatic tricuspid regurgitation. JACC Case Rep. 2023;23:102007.","journal-title":"JACC Case Rep"},{"key":"2190_CR32","doi-asserted-by":"publisher","unstructured":"Varma PK, Srimurugan B, Jose RL, Krishna N, Valooran GJ, Jayant A. Perioperative right ventricular function and dysfunction in adult cardiac surgery\u2014focused review (part 2\u2014management of right ventricular failure). Indian J Thorac Cardiovasc Surg [Internet]. 2022;38:157\u201366. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12055-021-01226-w","DOI":"10.1007\/s12055-021-01226-w"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02190-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02190-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02190-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:58:16Z","timestamp":1772096296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02190-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2190"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02190-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"1 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Drs. Puri and Altisent serve as a consultants to Products & Features. Dr. Puri is a consultant to VDyne, and PI of TRICAV-1 and TRICAV-2 trials. Dr. Chen has nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Blasco-Turri\u00f3n S, Briedis K, Est\u00e9vez-Loureiro R, S\u00e1nchez-Recalde A, Cruz-Gonz\u00e1lez I, Pascual I, et al. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation. JACC Cardiovasc Interv. 2024;17:60\u201372.\n                      This Analysis Describes the 1-year Clinical Endpoints from the TricValve single-arm Interventional CAVI Experience\n                      .Denby K, Spilias N, Harb SC, Kapadia SR, Puri R. Contrast-Sparing Intravascular Ultrasound\u2013Guided Caval Valve Implantation for Severe Symptomatic Tricuspid Regurgitation. JACC Case Rep. 2023;23:102007.\n                      This series describes contrast-sparing techniques for CAVI that utilize IVUS, important due to the prevalence of chronic kidney disease in patients with severe tricuspid regurgitation and right heart failure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Key References"}}],"article-number":"7"}}